BioSpace News Archive

Press Releases

PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer

October 19, 2025
·
11 min read
Press Releases

SystImmune Announces iza-bren Meets One of the Dual Primary Endpoints in the BL-B01D1-303 Trial in Recurrent or Metastatic NPC Patients with Results Presented as a Late-Breaking Oral Presentation at ESMO

October 19, 2025
·
6 min read
Press Releases

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress

October 19, 2025
·
9 min read
Press Releases

Tubulis Presents First Clinical Data from Phase I/IIa Trial for TUB-040 in Platinum-Resistant Ovarian Cancer (PROC) at ESMO 2025

October 19, 2025
·
6 min read
Press Releases

ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy

October 19, 2025
·
4 min read
Press Releases

Case Report | Preliminary Clinical Data of CARsgen’s Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia

October 19, 2025
·
5 min read
Press Releases

Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025

October 19, 2025
·
5 min read
Press Releases

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)

October 19, 2025
·
3 min read
Press Releases

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

October 19, 2025
·
5 min read
Press Releases

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

October 19, 2025
·
19 min read